These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37205914)

  • 21. Corrigendum: Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes.
    Arjmand B; Kokabi Hamidpour S; Alavi-Moghadam S; Yavari H; Shahbazbadr A; Rezaei-Tavirani M; Gilany K; Larijani B
    Front Pharmacol; 2022; 13():892656. PubMed ID: 35586055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrigendum: 7-Ethyl-10-Hydroxycamptothecin, A DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth.
    Wang A; Li L; Li M; Wang S; Wang C
    Front Pharmacol; 2021; 12():757060. PubMed ID: 34526906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corrigendum: Machine Learning Enables Accurate and Rapid Prediction of Active Molecules Against Breast Cancer Cells.
    He S; Zhao D; Ling Y; Cai H; Cai Y; Zhang J; Wang L
    Front Pharmacol; 2022; 13():901513. PubMed ID: 35707400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and validation of stemness-related lncRNA prognostic signature for breast cancer.
    Li X; Li Y; Yu X; Jin F
    J Transl Med; 2020 Aug; 18(1):331. PubMed ID: 32867770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells through Wnt/β-catenin Signaling Pathway.
    Tang W; Li M; Qi X; Li J
    Cancer Res Treat; 2020 Oct; 52(4):1084-1102. PubMed ID: 32599982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrigendum: Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR.
    Huang JM; Ren RY; Bao Y; Guo JC; Xiang W; Jing XZ; Shi J; Zhang GX; Li L; Tian Y; Kang H; Guo FJ
    Front Pharmacol; 2018; 9():1128. PubMed ID: 30344491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corrigendum: Danshensu methyl ester enhances autophagy to attenuate pulmonary fibrosis by targeting lncIAPF-HuR complex.
    Zhu Q; Wang J; Ji Y; Luan J; Yue D; Liu W; Li H; Zhang J; Qu G; Lv C; Song X
    Front Pharmacol; 2022; 13():1086927. PubMed ID: 36534046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy-induced adenosine A2B receptor expression mediates epigenetic regulation of pluripotency factors and promotes breast cancer stemness.
    Lan J; Wei G; Liu J; Yang F; Sun R; Lu H
    Theranostics; 2022; 12(6):2598-2612. PubMed ID: 35401817
    [No Abstract]   [Full Text] [Related]  

  • 29. ETV4 promotes breast cancer cell stemness by activating glycolysis and CXCR4-mediated sonic Hedgehog signaling.
    Zhu T; Zheng J; Zhuo W; Pan P; Li M; Zhang W; Zhou H; Gao Y; Li X; Liu Z
    Cell Death Discov; 2021 May; 7(1):126. PubMed ID: 34052833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corrigendum: A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5.
    Xin Z; Jin C; Chao L; Zheng Z; Liehu C; Panpan P; Weizong W; Xiao Z; Qingjie Z; Honggang H; Longjuan Q; Xiao C; Jiacan S
    Front Pharmacol; 2021; 12():. PubMed ID: 33981210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corrigendum: Docetaxel-loaded novel nano-platform for synergistic therapy of non-small cell lung cancer.
    Feng X; Xiong X; Ma S
    Front Pharmacol; 2022; 13():964540. PubMed ID: 36160393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corrigendum: Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose.
    Maisto R; Trotta MC; Petrillo F; Izzo S; Cuomo G; Alfano R; Hermenean A; Barcia JM; Galdiero M; Platania CBM; Bucolo C; D'Amico M
    Front Pharmacol; 2020; 11():871. PubMed ID: 32612528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer.
    Zhang K; Liu P; Tang H; Xie X; Kong Y; Song C; Qiu X; Xiao X
    Front Pharmacol; 2020; 11():1107. PubMed ID: 32765285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corrigendum: Role of selective histone deacetylase 6 inhibitor ACY-1215 in cancer and other human diseases.
    Li J; Yu M; Fu S; Liu D; Tan Y
    Front Pharmacol; 2022; 13():1117936. PubMed ID: 36588693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells.
    Wang X; Hui R; Chen Y; Wang W; Chen Y; Gong X; Jin J
    Front Pharmacol; 2020; 11():603491. PubMed ID: 33381044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrigendum: Scopoletin Suppresses Activation of Dendritic Cells and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling.
    Zhang F; Zhang Y; Yang T; Ye ZQ; Tian J; Fang HR; Han JJ; Wang ZZ; Li X
    Front Pharmacol; 2019; 10():1037. PubMed ID: 31543821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corrigendum: Notoginsenoside R1 Reverses Abnormal Autophagy in Hippocampal Neurons of Mice With Sleep Deprivation Through Melatonin Receptor 1A.
    Cao Y; Li Q; Zhou A; Ke Z; Chen S; Li M; Gong Z; Wang Z; Wu X
    Front Pharmacol; 2021; 12():832126. PubMed ID: 35126155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corrigendum: Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury
    Ye J; Lu S; Wang M; Ge W; Liu H; Qi Y; Fu J; Zhang Q; Zhang B; Sun G; Sun X
    Front Pharmacol; 2021; 12():671318. PubMed ID: 33967813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling.
    Zhang Z; Han H; Rong Y; Zhu K; Zhu Z; Tang Z; Xiong C; Tao J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):291. PubMed ID: 30486896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy.
    Wang X; Yin G; Zhang W; Song K; Zhang L; Guo Z
    Front Pharmacol; 2023; 14():1220144. PubMed ID: 37305537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.